{"log_id": 1919693255622327642, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0.01343, "average": 0.952511, "min": 0.553331}, "location": {"width": 559, "top": 170, "height": 34, "left": 112}, "words": "腺炎、史-约综合征以及严重的肝功能异常(如黄疸和肝炎)。"}, {"probability": {"variance": 0.004733, "average": 0.959185, "min": 0.767608}, "location": {"width": 225, "top": 224, "height": 24, "left": 109}, "words": "和噻唑烷二酮类合用治疗"}, {"probability": {"variance": 0.011985, "average": 0.953096, "min": 0.369809}, "location": {"width": 920, "top": 262, "height": 38, "left": 148}, "words": "在一项为期24周的瑞格列奈一罗格列酮或者瑞格列奈一吡格列合用治疗(共有250名患者参与了合"}, {"probability": {"variance": 0.015125, "average": 0.947621, "min": 0.432494}, "location": {"width": 940, "top": 308, "height": 37, "left": 109}, "words": "并用药试验)的临床试验中,用纽的低血糖的(血糖<50mg/dL)发生率为7%,瑞格列奈单用纽为7"}, {"probability": {"variance": 0.045918, "average": 0.774457, "min": 0.4622}, "location": {"width": 173, "top": 364, "height": 26, "left": 105}, "words": "噻唑烷二酮组为20"}, {"probability": {"variance": 0.005897, "average": 0.972113, "min": 0.556883}, "location": {"width": 914, "top": 400, "height": 37, "left": 152}, "words": "50名瑞格列奈一噻唑烷二酮合并用药的病人中有12名出现了外周型水肿,124名单用噻唑烷二酮治"}, {"probability": {"variance": 0.005455, "average": 0.974066, "min": 0.620356}, "location": {"width": 943, "top": 447, "height": 37, "left": 104}, "words": "疗的患者中有3例报道,而瑞格列奈单用组中没有报道该不良反应。当对各治疗组的脱火率进行校正后"}, {"probability": {"variance": 0.0139, "average": 0.947964, "min": 0.406171}, "location": {"width": 962, "top": 493, "height": 37, "left": 106}, "words": "瑞格奈一噻唑烷二酮合用组的患者每24周发生外周型水肿的几率为5%,单用噻唑烷二酮组的发生儿率"}, {"probability": {"variance": 0.008186, "average": 0.964026, "min": 0.511421}, "location": {"width": 957, "top": 539, "height": 37, "left": 109}, "words": "为4%。有报道,250名瑞格训奈一噻唑烷二酮合用红患者中有2名(0.8%)出现伴随充血性心肌衰竭的外"}, {"probability": {"variance": 0.00038, "average": 0.989292, "min": 0.90635}, "location": {"width": 959, "top": 586, "height": 37, "left": 105}, "words": "周型水肿。这两名患者均有冠心病史,并在服用利尿剂后恢复。单用治疗组中并没有相关可比较的案例报"}, {"probability": {"variance": 0, "average": 0.985099, "min": 0.985099}, "location": {"width": 25, "top": 644, "height": 25, "left": 104}, "words": "道"}, {"probability": {"variance": 0.018432, "average": 0.931459, "min": 0.479799}, "location": {"width": 919, "top": 679, "height": 36, "left": 148}, "words": "瑞格列奈一噻唑烷二酮合用组的平均体重变化为+4.9kg瑞格列奈一噻唑烷二酮红没有患者出现转氨酶"}, {"probability": {"variance": 0.000131, "average": 0.99082, "min": 0.963088}, "location": {"width": 308, "top": 734, "height": 27, "left": 107}, "words": "升高(定义为正常值上限的3倍"}, {"probability": {"variance": 0.04265, "average": 0.877125, "min": 0.519478}, "location": {"width": 72, "top": 782, "height": 26, "left": 111}, "words": "〖禁忌】"}, {"probability": {"variance": 0.030126, "average": 0.87202, "min": 0.568794}, "location": {"width": 124, "top": 830, "height": 24, "left": 147}, "words": "以卜情况禁用"}, {"probability": {"variance": 0.002114, "average": 0.977137, "min": 0.816321}, "location": {"width": 457, "top": 870, "height": 33, "left": 165}, "words": "已知对端格列奈或本晶中的任何赋型剂过敏的患者"}, {"probability": {"variance": 0.010328, "average": 0.929301, "min": 0.624075}, "location": {"width": 597, "top": 918, "height": 31, "left": 145}, "words": "21型糖尿病患者胰岛素依赖型,1DDM),C-肽阴性糖尿病患者"}, {"probability": {"variance": 0.003073, "average": 0.966889, "min": 0.83961}, "location": {"width": 393, "top": 966, "height": 30, "left": 145}, "words": "3伴随或不伴昏迷的糖尿病酮症酸中毒患者"}, {"probability": {"variance": 6.2e-05, "average": 0.995435, "min": 0.978266}, "location": {"width": 106, "top": 1018, "height": 24, "left": 116}, "words": "【注意事项】"}, {"probability": {"variance": 0.011649, "average": 0.964816, "min": 0.490821}, "location": {"width": 698, "top": 1056, "height": 33, "left": 151}, "words": "1同其它大多数口服促胰岛素分泌降血糖药物一样,瑞格列奈片也可致低糖"}, {"probability": {"variance": 0.007336, "average": 0.958844, "min": 0.674378}, "location": {"width": 925, "top": 1097, "height": 46, "left": 143}, "words": "2与甲双胍合用会增加发生低血糖的危险性、如果合并用药后仍发生持纹高血糖,则不能再用口服降"}, {"probability": {"variance": 0.00809, "average": 0.973989, "min": 0.625898}, "location": {"width": 353, "top": 1157, "height": 26, "left": 105}, "words": "血糖药控制血糖,而需改用胰岛治疗"}, {"probability": {"variance": 0.002173, "average": 0.978206, "min": 0.769724}, "location": {"width": 923, "top": 1197, "height": 36, "left": 144}, "words": "3在发生应激反应时,如发烧、外伤、感染或手术,可能会出现血糖控制失败。这时,有必要停止服用"}, {"probability": {"variance": 5e-06, "average": 0.998234, "min": 0.991149}, "location": {"width": 312, "top": 1249, "height": 32, "left": 105}, "words": "瑞格列奈而进行短期的胰岛素治疗"}, {"probability": {"variance": 7.7e-05, "average": 0.996518, "min": 0.953429}, "location": {"width": 581, "top": 1293, "height": 34, "left": 144}, "words": "4瑞格列奈片尚未在18岁以下或75岁以上的患者中进行过研究"}, {"probability": {"variance": 0.000141, "average": 0.993062, "min": 0.951925}, "location": {"width": 922, "top": 1337, "height": 37, "left": 145}, "words": "5应尽量避免将瑞格列奈与吉非贝齐合用。如果必须合用,应严密监测患者的血糖水平。因为可能需要"}, {"probability": {"variance": 0.002373, "average": 0.977762, "min": 0.825959}, "location": {"width": 225, "top": 1394, "height": 28, "left": 109}, "words": "减少瑞格列奈的用药剂量"}, {"probability": {"variance": 1e-05, "average": 0.997476, "min": 0.989913}, "location": {"width": 617, "top": 1435, "height": 34, "left": 146}, "words": "6与其它口服降血糖药一样,患者必须慎用以避免开车时发生低血糖"}, {"probability": {"variance": 0.001966, "average": 0.980599, "min": 0.762033}, "location": {"width": 917, "top": 1480, "height": 37, "left": 151}, "words": "7肾功能不全:虽然瑞格列奈水平与肌酐清除率仅有微弱的联系,但本品的总血浆清除率在严重肾功能"}, {"probability": {"variance": 0.010388, "average": 0.966157, "min": 0.381952}, "location": {"width": 959, "top": 1528, "height": 37, "left": 105}, "words": "损伤的患者中略有降低。由于肾功能损伤的糖尿病患者对胰岛素敏感性增强,这些患者增加剂量时应"}], "language": 3}